Trial Profile

Effect of food on the Pharmacokinetics of two formulations of a New cetp inhibitor in healthy Volunteers

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 09 Apr 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs DRL 17822 (Primary)
Indications Hypercholesterolaemia
Focus Pharmacokinetics
Sponsors Dr Reddys Laboratories

Most Recent Events

06 Apr 2020 Results from four phase 1 studies: study 1: first-in-human single dose phase, study 2: single dose food interaction study, study 3: two-week once daily multiple dose study and study 4: (part A and B) was a single dose food and formulation interaction study on the population pharmacokinetics of DRL-17822 in healthy male volunteers were published in the British Journal of Clinical Pharmacology
29 Oct 2015 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com